[Federal Register Volume 77, Number 49 (Tuesday, March 13, 2012)]
[Notices]
[Pages 14837-14838]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5998]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on April 16-17, 2012. A sample of 
agenda items to be discussed during the public session includes: (1) 
Fundamental concepts in patient advocacy; (2) electronic signatures for 
documents that are required to be signed in accordance with U.S. 
Nuclear Regulatory Commission (NRC) regulations; (3) medical-related 
events from fiscal year 2011; (4) an update on proposed regulatory 
changes for Permanent Implant Brachytherapy programs; (5) the status of 
the Commission Paper on data collection for Patient Release; (6) a 
status update on 10 CFR Part 35 rulemaking; (7) medical use of radium-
223 chloride; (8) an update on strontium breakthrough with rubidium-82 
generators from NRC and FDA perspectives; and (9) half-life activity as 
a function of solar activity. The agenda is subject to change. The 
current agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by emailing Ms. Sophie 
Holiday at the contact information below.
    Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Session: April 16, 2012, from 8 a.m. to 
10:45 a.m. This session will be closed so that ACMUI members can 
prepare for an upcoming Commission briefing.
    Date and Time for Open Sessions: April 16, 2012, from 10:45 a.m. to 
5 p.m. and April 17, 2012, from 8 a.m. to 12:30 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-

[[Page 14838]]

B3, 11545 Rockville Pike, Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Holiday using the information below. The meeting will also be webcast 
live: http://www.nrc.gov/public-involve/public-meetings/webcast-live.html.
    Contact Information: Sophie J. Holiday, email: 
sophie.holiday@nrc.gov, telephone: (301) 415-7865.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday at the contact information listed above. 
All submittals must be received by April 9, 2012, and must pertain to 
the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript will be available on ACMUI's Web site 
(http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about 
May 18, 2012. A meeting summary will be available on ACMUI's Web site 
(http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/
) on or about May 29, 2012.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
attendance.

    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: March 7, 2012.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2012-5998 Filed 3-12-12; 8:45 am]
BILLING CODE 7590-01-P